165 related articles for article (PubMed ID: 24114686)
1. ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study).
Güçlü A; Germans T; Witjas-Paalberends ER; Stienen GJ; Brouwer WP; Harms HJ; Marcus JT; Vonk AB; Stooker W; Yilmaz A; Klein P; Ten Berg JM; Kluin J; Asselbergs FW; Lammertsma AA; Knaapen P; van Rossum AC; van der Velden J
Neth Heart J; 2013 Dec; 21(12):567-71. PubMed ID: 24114686
[TBL] [Abstract][Full Text] [Related]
2. Disease Stage-Dependent Changes in Cardiac Contractile Performance and Oxygen Utilization Underlie Reduced Myocardial Efficiency in Human Inherited Hypertrophic Cardiomyopathy.
Güçlü A; Knaapen P; Harms HJ; Parbhudayal RY; Michels M; Lammertsma AA; van Rossum AC; Germans T; van der Velden J
Circ Cardiovasc Imaging; 2017 May; 10(5):. PubMed ID: 28476777
[TBL] [Abstract][Full Text] [Related]
3. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
[TBL] [Abstract][Full Text] [Related]
4. Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy.
Parbhudayal RY; Güçlü A; Zweerink A; Biesbroek PS; Croisille P; Clarysse P; Michels M; Stooker W; Vonk ABA; van der Ven PM; van Rossum AC; van der Velden J; Nijveldt R
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1089-1100. PubMed ID: 30825136
[TBL] [Abstract][Full Text] [Related]
5. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
6. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
7. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy.
Paar V; Haslinger M; Krombholz-Reindl P; Pittner S; Neuner M; Jirak P; Kolbitsch T; Minnich B; Schrödl F; Kaser-Eichberger A; Kopp K; Koller A; Steinwender C; Lichtenauer M; Monticelli FC; Seitelberger R; Hoppe UC; Dinges C; Motloch LJ
Front Pharmacol; 2023; 14():1264216. PubMed ID: 38074139
[No Abstract] [Full Text] [Related]
9. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
10. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
[TBL] [Abstract][Full Text] [Related]
11. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
12. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
14. Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.
Timmer SA; Germans T; Götte MJ; Rüssel IK; Dijkmans PA; Lubberink M; ten Berg JM; ten Cate FJ; Lammertsma AA; Knaapen P; van Rossum AC
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):779-88. PubMed ID: 20069294
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.
Wijnker PJM; Sequeira V; Kuster DWD; Velden JV
Antioxid Redox Signal; 2019 Aug; 31(4):318-358. PubMed ID: 29490477
[No Abstract] [Full Text] [Related]
16. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.
Theis JL; Bos JM; Theis JD; Miller DV; Dearani JA; Schaff HV; Gersh BJ; Ommen SR; Moss RL; Ackerman MJ
Circ Heart Fail; 2009 Jul; 2(4):325-33. PubMed ID: 19808356
[TBL] [Abstract][Full Text] [Related]
18. Revelation of an obstructive hypertrophic cardiomyopathy in an elderly patient.
Patanè S; Marte F; Portaro A
Int J Cardiol; 2010 Nov; 145(2):e41-e43. PubMed ID: 19181403
[TBL] [Abstract][Full Text] [Related]
19. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
Witjas-Paalberends ER; Piroddi N; Stam K; van Dijk SJ; Oliviera VS; Ferrara C; Scellini B; Hazebroek M; ten Cate FJ; van Slegtenhorst M; dos Remedios C; Niessen HW; Tesi C; Stienen GJ; Heymans S; Michels M; Poggesi C; van der Velden J
Cardiovasc Res; 2013 Aug; 99(3):432-41. PubMed ID: 23674513
[TBL] [Abstract][Full Text] [Related]
20. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
Timmer SA; Germans T; Brouwer WP; Lubberink M; van der Velden J; Wilde AA; Christiaans I; Lammertsma AA; Knaapen P; van Rossum AC
Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
